HomeALOPM • EPA
add
Oncodesign Precision Medicine Opm SA
Previous close
€0.45
Year range
€0.28 - €1.09
Market cap
8.22M EUR
Avg Volume
30.78K
P/E ratio
1.31
Dividend yield
-
Primary exchange
EPA
Market news
Financials
Income Statement
Revenue
Net income
| (EUR) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 371.41K | 16.23% |
Operating expense | 864.67K | 13.10% |
Net income | 4.92M | 370.80% |
Net profit margin | 1.33K | 333.00% |
Earnings per share | — | — |
EBITDA | 4.97M | 342.94% |
Effective tax rate | -3.26% | — |
Balance Sheet
Total assets
Total liabilities
| (EUR) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.45M | — |
Total assets | 19.59M | — |
Total liabilities | 9.20M | — |
Total equity | 10.39M | — |
Shares outstanding | 18.12M | — |
Price to book | 0.79 | — |
Return on assets | 62.35% | — |
Return on capital | 72.16% | — |
Cash Flow
Net change in cash
| (EUR) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | 4.92M | 370.80% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
Oct 2022
Website
Employees
14
